Clinical Trial

Trial Protocol ID USOR 23266_TOL2506A-EXT_OVELIA

Trial Description

Open-label, Safety Extension Study for Subjects with Hormone-Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Who Have Completed the OVarian Suppression Evaluating Subcutaneous LeuprolIde Acetate in Breast Cancer (OVELIA) Study (TOL2506A-EXT)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Carol Tweed, MD

Disease Types

Sponsor

  • Tolmar, Inc.

ClinicalTrials.gov NCT ID

  • NCT05645536